NCT06654687View on ClinicalTrials.gov

Transthoracic Echocardiographic Monitoring of Cardiac Output Effects of Colloid Preload and Crystalloid Coload During Cesarean Delivery Under Spinal Anesthesia

NACompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

October 27, 2024

Primary Completion Date

February 15, 2025

Study Completion Date

March 1, 2025

Conditions
PregnancyCesarean DeliverySpinal Anesthesia Induced HypotensionCardiac Output MeasurementVolume Status
Interventions
DEVICE

Transthoracic Echocardiography

Transthoracic Echocardiography will be used to measure the changes in stroke volume and cardiac output.

DRUG

Ringer lactate 1000 ml

Patients will receive 1000 mL of Ringer's lactate solution over 15 minutes.

DRUG

Albumin

Patients will receive 250 mL of human albumin 5% over 10 minutes

DRUG

Ringer lactate 750 ml

Patients will receive 750 mL of Ringer's lactate solution over 15 minutes.

Trial Locations (1)

Unknown

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Sameh Fathy

OTHER

NCT06654687 - Transthoracic Echocardiographic Monitoring of Cardiac Output Effects of Colloid Preload and Crystalloid Coload During Cesarean Delivery Under Spinal Anesthesia | Biotech Hunter | Biotech Hunter